Afuco™ Anti-Human HBEGF ADCC Therapeutic Antibody (KHK2866), ADCC Enhanced
Anti-HBEGF ADCC Enhanced Antibody (KHK2866) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody targeting anti-heparin-binding EGF-like growth factor (HB-EGF), was being developed for the treatment of dvanced solid tumors and ovarian cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-326CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | HBEGF |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |